达巴万星产品是Dalbavancin is a second-generation lipoglycopeptide antibiotic that is active against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), and minimum inhibitory concentrations (MICs) are consistently <0.125 µg/ml, much lower than most other anti-MRSA agents.